Eysuvis 0.25% (2.5 mg/mL) ophthalmic suspension Images
Generic Name: loteprednol
This medication has been identified as Eysuvis 0.25% (2.5 mg/mL) ophthalmic suspension. It is supplied by Kala Pharmaceuticals, Inc.
Eysuvis is used in the treatment of Dry Eye Disease and belongs to the drug class ophthalmic steroids. Risk cannot be ruled out during pregnancy. Eysuvis 0.25% (2.5 mg/mL) ophthalmic suspension is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Eysuvis
- Generic Name
- loteprednol
- Strength
- 0.25% (2.5 mg/mL) ophthalmic suspension
- Availability
- Prescription only
- Drug Class
- Ophthalmic steroids
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Kala Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 71571-0333
More about Eysuvis (loteprednol ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic steroids
- Breastfeeding
- En español
Patient resources
Other brands
Lotemax, Alrex, Lotemax SM, Inveltys
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
